RENAISSANCE TECHNOLOGIES LLC

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in MLYS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$10,206,534

-$163,518 QoQ

Shares Held

378,300

-1.2% QoQ

Ownership

0.428%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#55

of 224 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,579,858 across 312 Biotechnology names. MLYS ranks #49 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,206,534	378,300	-1.2%	Shares	Sole	2026-08-13
2026-03-31	$10,370,052	382,800	+18.8%	Shares	Sole	2026-05-14
2025-12-31	$11,689,009	322,100	+579.5%	Shares	Sole	2026-02-12
2025-09-30	$1,797,408	47,400	-73.2%	Shares	Sole	2025-11-13
2025-06-30	$2,393,808	176,926	-0.2%	Shares	Sole	2025-08-13
2025-03-31	$2,815,524	177,300	+48.4%	Shares	Sole	2025-05-14
2024-12-31	$1,471,045	119,500	+15.1%	Shares	Sole	2025-02-13
2024-09-30	$1,257,018	103,800	+68.0%	Shares	Sole	2024-11-13
2024-06-30	$723,060	61,800	+95.0%	Shares	Sole	2024-08-09
2024-03-31	$409,247	31,700	+24.3%	Shares	Sole	2024-05-13
2023-12-31	$219,300	25,500	-73.4%	Shares	Sole	2024-02-13
2023-09-30	$910,011	95,690	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.